Evaluation of efficacy of propranolol on hemangioma and lymphangioma.
Not Applicable
- Conditions
- hemangioma, lymphangioma
- Registration Number
- JPRN-UMIN000004626
- Lead Sponsor
- Kanazawa Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe heart disease. 2. Hypotension. 3. Woman who are pregnant or breast feeding, and woman of childbearing potential. 4. Patient who has drug allergy, and patient with the past of serious side effect by the propranolol drug. 5. Patient who was considered ineligible by the investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A change of the lesion size.
- Secondary Outcome Measures
Name Time Method A side effect by blood pressure, the blood sugar level.